This National Institute on Drug Abuse (NIDA)-funded postdoctoral program is offered by the University of California, San Francisco (UCSF) Department of Psychiatry and Weill Institute for Neurosciences. Our program is one of the few that trains scientists in treatment and service research. Scholars work with a preceptor to design and implement studies on treatment of substance use disorders (SUD), including nicotine, cannabis, opioids, and other substances. Scholars also select a specific area of focus for independent research. Current research interests of faculty include trials of efficacy and effectiveness of psychosocial and pharmacologic treatment of substance use disorders, including:
- Substance use disorders including cannabis, tobacco and opioids
- Innovative methodology, including internet-based studies
- Treatment of complex patients in health care settings
- Diagnostic techniques and research on treatment tailored for HIV-positive substance users with psychiatric and medical disorders
- Research on provision of services to substance-using populations
- Instrument development in substance use treatment
A variety of university-affiliated and community substance use treatment programs are available as research sites. These include inpatient- and outpatient-setting programs that treat a range of problems related to SUD treatment, including dependence on stimulants, cannabis, nicotine, alcohol, and opiates. Our program encourages close research involvement with a preceptor, and involvement in selected classes, seminars, and grant preparation.
The training program is supported in part by the Western States Node of the NIDA Clinical Trials Network. Resources from other significant extramural funding and R01-level grants are also routinely available to scholars.
Our unifying philosophy is:
- SUD treatment and services research must be methodologically excellent and clinically relevant.
- Problems related to substance use are best attacked from a multidisciplinary perspective.
- Integration of knowledge of various intellectual domains is essential to the development of effective treatment.
Because our philosophy implies that the quality of the postdoctoral program depends on the quality of the scholars, faculty, and environment, rather than on any particular class or activity, we energetically recruit to obtain high-quality applicants into a research environment where they will work under the guidance of research-sophisticated investigators.
Our postdoctoral program is directed by a five-member site directors group, an executive committee, and core faculty, representing psychiatry, public health and policy, behavioral sciences, medicine, and biostatistics. They represent a diverse, but overlapping, range of research interests.
Program faculty are:
- Director and Associate Director (also Faculty Mentors)
- Site Directors (also Faculty Mentors)
- Executive Committee Members (also Faculty Mentors)
- Additional Faculty Mentors
- Brian Borsari, PhD (San Francisco VA Health Care System)
- Cynthia Campbell, PhD (Kaiser Permanente Division of Research)
- Phillip Coffin, MD, MIA (San Francisco Department of Public Health)
- Gary Humfleet, PhD (Langley Porter Psychiatric Hospital and Clinics)
- Mallory Johnson, PhD (UCSF Center for AIDS Prevention Studies)
- Mandana Khalili, MD (Zuckerberg San Francisco General)
- Kelly Knight, PhD (UCSF Laurel Heights)
- Paula Lum, MD, MPH (Zuckerberg San Francisco General)
- Linda J. Pfiffner, PhD (Langley Porter Psychiatric Hospital and Clinics)
- Elise Riley, PhD (Zuckerberg San Francisco General)
- Glenn-Milo Santos, PhD, MPH (UCSF School of Nursing)
- Janine Cataldo, RN, PhD (UCSF School of Nursing)
- Carol Dawson-Rose, RN, PhD (UCSF School of Nursing)
- Sharon M. Hall, PhD (Langley Porter Psychiatric Hospital and Clinics)
- Annesa Flentje, PhD (UCSF School of Nursing)
- Barrot Lambdin, PhD, MPH (UCSF Mission Bay)
- Christina Mangurian, MD, MAS (UCSF School of Medicine)
- Jennifer Manuel, PhD (San Francisco VA Health Care System)
- Meredith Meacham, PhD, MPH (Zuckerberg San Francisco General)
- Dieter Meyerhoff, PhD (San Francisco VA Health Care System)
- David Pennington, PhD (San Francisco VA Health Care System)
- Mark Rubinstein, MD (UCSF Laurel Heights)
- Parya Saberi, PharmD (UCSF School of Medicine)
- Jason Satterfield, PhD (UCSF Department of Medicine)
- Laura Schmidt, PhD, MSW, MPH (UCSF Laurel Heights)
- Christopher Stauffer, MD (San Francisco VA Health Care System)
- Andy Tompkins, MD, MHS (Zuckerberg San Francisco General)
- Constance M. Weisner, DrPH, MSW (Langley Porter Psychiatric Hospital and Clinics; Kaiser Permanente Division of Research)
- Mark von Zastrow, MD, PhD (UCSF Mission Bay)
- Kelly Young-Wolff, PhD, MPH (Kaiser Permanente Division of Research)
- Clinical Faculty Members
- Timothy P. Carmody, PhD (San Francisco VA Health Care System)
- Caitlin Costello, MD (Langley Porter Psychiatric Hospital and Clinics)
- Valerie Gruber, PhD, MPH (Zuckerberg San Francisco General)
- Ellen Herbst, MD (San Francisco VA Health Care System)
- Michael Hoefer, MD (San Francisco VA Health Care System)
Postdoctoral training program
Each year, scholars participate in a core Postdoctoral Research Seminar and the Writers' Task Force—a group that facilitates, supports, and encourages the publication of manuscripts.
As part of their research training, scholars interact daily with investigators who guide them in responsible conduct of research and in solving the special ethical dilemmas of treatment and clinical research. Most scholars also take one of the several advanced statistics courses offered by the UCSF Department of Epidemiology & Biostatistics. Scholars' research projects and those of their mentors are closely tied. As scholars move from Year 1 to Year 2, they progress from a project designed by their mentor to a more independently conceived project, which they lead.
Goals for postdoctoral scholars
At the end of our postdoctoral program, scholars are expected to have acquired the following competencies and completed the following tasks:
- Gained knowledge of substance use and its treatment
- Advanced their knowledge of statistical and methodological techniques needed for clinical and services research
- Understand SUD treatment systems and substance research projects
- Conducted at least two research projects in a clinical setting (one designed by their preceptor; and one of their own design, for which they have primary responsibility)
- Made multiple internal presentations
- Made at least two presentations of their work at national meetings
- Published one to three journal articles
- Submitted a small grant application to local funding sources
- Published additional manuscripts from the work completed as a scholar during the two years following enrollment in our program
Support for postdoctoral scholars
Scholars are funded by multiple sources. Stipend levels are set by the National Institutes of Health (NIH), based on years of related experience. Scholars are provided with other research support, including travel to at least one annual professional meeting and other support required for a useful training experience, including statistical consulting, some administrative and clerical support, and access to computers for writing and data analyses.
Background of former postdoctoral scholars
Our postdoctoral scholars have come from a variety of fields, including clinical psychology, counseling psychology, developmental psychology, neuroscience, nursing, political science, psychiatry, pharmacology, public health, social work, and social psychology. Recent trainee research projects include:
- Studies of social media-based interventions
- Studies of how substance use affects HIV pre-exposure prophylaxis adherence
- Treatment challenges for justice-involved youth
- Research on substance use among sexual and gender minority people
- Development of computerized substance use screening in health care settings
- Vocational issues among methadone outpatients
- Social identities and treatment outcomes among alcohol and cocaine users in private treatment
- The effects of acute nicotine use on cue-induced cocaine craving
- Mood management intervention for injection drug use patients
- Childhood trauma and PTSD in inpatient substance use treatment
- Studies of the relationship of readiness to change and depression to nicotine dependence
- Studies of service utilization and outcome among older adult substance users
- Studies of drug and alcohol treatment within integrated health care systems
Success of our postdoctoral graduates
We admit two to four scholars each year. Graduates of our postdoctoral program have been placed at numerous high-caliber institutions where research is valued.
Please direct information requests, application packets, and letters of recommendation submissions to Jaime Smith at [email protected].
For consideration into the postdoctoral program, please send an application packet consisting of your (1) cover letter, (2) curriculum vitae, (3) statement of research interests, and (4) representative work. Statement of research interests should include the following items:
- History of research projects
- Current interests
- What you would like to learn and accomplish during your postdoctoral traineeship at UCSF
- A list of program faculty with whom you would like to work
Two letters of reference should be sent directly from the recommenders.
Representative work can include dissertation chapters if no publications are available. Electronic submission of materials (except reference letters) is strongly encouraged. The application period is open until filled.
All applicants must have completed their doctorate at the time of entry into the program and be a U.S. citizen or have Lawful Permanent Residency (Green Card) status at the time of appointment.
Useful resources and links
- Frequently asked questions about the mentorship process and applying to our program
- UCSF Office for Postdoctoral Scholars
- Postdoctoral appointment and benefits plan information
- UCSF Campus Life Services (information on housing, fitness and recreation, shuttle transportation, and more)
Current postdoctoral scholars
Noah received his PhD in Behavioral Neuroscience at Oregon Health and Science University. His dissertation research used behavioral genetic mouse models to examine interactions between nicotine and alcohol on reward and neuroadaptation. Noah recently completed a postdoctoral fellowship at UCSF in the Drug Abuse Treatment and Services Training Program. During his postdoctoral training he worked on a number of different research projects that examined the co-use of tobacco with alcohol and other drugs of abuse. This includes the etiology of alcohol and tobacco/nicotine co-use, how alcohol abuse alters the rate of nicotine metabolism, and the use of electronic cigarettes by clients in substance use disorder treatment. As a postdoc at UCSF Noah was awarded a F32 NRSA from NIDA and a pilot grant through the UCSF TCORS to conduct a human subjects research study that evaluated the abuse potential of electronic cigarettes when used in combination with alcohol.
Anna Harrison received her PhD in clinical psychology from Northwestern University in 2016, where she studied the effects of incarceration on mental health and substance use. She completed her predoctoral clinical internship at the VA Palo Alto Health Care System. During her time in the postdoctoral fellowship program, Dr. Harrison worked to disseminate substance use treatments to youth involved in the justice system. Her current research interests include developing digital health interventions to improve substance use treatment for justice-involved populations. Dr. Harrison will be working as a suicide prevention psychologist in the San Francisco VA Health Care System.
Jin Kim-Mozeleski, PhD
Jin Kim-Mozeleski was a T32 postdoctoral fellow from August 2014–July 2017, where she focused her research on nicotine dependence and smoking cessation among underserved populations. Her current work examines a key aspect of socioeconomic stress as it relates to disparities in tobacco use and dependence—the experience of hunger and food insecurity. She is currently Principal Investigator of a NIDA K01 career development award, where she is drawing on quantitative and qualitative methodologies to develop and implement tailored smoking cessation outreach in community settings. Dr. Kim-Mozeleski received her PhD in social psychology from the University of California Davis. Since 2017, she is assistant professor at the University of Massachusetts Amherst School of Public Health and Health Sciences, where she is faculty in the Department of Health Promotion and Policy, and core faculty of the Center for Community Health Equity Research.
Meredith Meacham, PhD, MPH, is an epidemiologist who uses multidisciplinary analytic methods to understand patterns of polysubstance use and related health conditions (e.g., substance use disorders, overdose, mental illness, HIV). As a postdoctoral fellow, she contributes to development and analysis of tailored smoking cessation interventions delivered through social media with Danielle Ramo, PhD; works on cohort studies examining the health of unstably housed women with Elise Riley, PhD; and designs text analysis projects to explore how people who use cannabis use social media and online communities to seek and share health information. She earned her PhD in public health (global health) from the University of California San Diego/San Diego State University Joint Doctoral Program, with a dissertation on polydrug use and risk of HIV and overdose in the U.S.-Mexico border region. Meredith also has an MPH from the University of Washington and an AB from the University of Chicago. She completed the program on December 31, 2018.
Erik Storholm, PhD
Erik Storholm, PhD is currently a behavioral scientist at the RAND Corporation, a licensed clinical psychologist, and a combination prevention core scientist at UCLA's Center for HIV Identification, Prevention, and Treatment Services (CHIPTS). After completing two years in the Substance Abuse Treatment Services and Research fellowship program at UCSF he was a scholar in the HIV/AIDS, Substance Abuse and Trauma Training Program at UCLA. While at UCSF he completed a study assessing changes in risk perception and behavior, substance use, and medication adherence among young sexual minority men prescribed pre-exposure prophylaxis (PrEP) to prevent HIV infection. Storholm's primary research interests are in the development and evaluation of clinical interventions that focus on mental health, substance abuse, and the prevention of HIV/STI transmission among high-risk minority populations. Currently, Storholm is leading several NIH-funded projects in the area of biobehavioral HIV prevention uptake and adherence. Storholm received his Ph.D. from New York University and completed his clinical training in the Departments of Psychiatry at Columbia University Medical Center and the Mount Sinai Hospital System in New York City. During his doctoral studies he was a fellow in the NIH-funded Clinical and Translational Science pre-doctoral training program at the NYU Langone School of Medicine. Storholm also maintains a private practice in Los Angeles.
Erin Vogel is a postdoctoral fellow at UCSF, funded by an individual fellowship award through the Tobacco-Related Diseases Research Program. Her current research focuses on social influences on adolescent e-cigarette use and the development and implementation of digital interventions for smoking cessation delivered on social media. Dr. Vogel was appointed to the program on July 1, 2017 after completing her PhD in experimental (social) psychology at the University of Toledo (Toledo, Ohio) in May 2017. She is a member of the Research on Addictions and Digital Interventions lab (principal investigator: Danielle Ramo).Her personal website can be found at erin-vogel.com.